What label best describes this news article?
Pfizer Celebrex Trial Stopped After Heart Attacks  NEW YORK (Reuters) - Pfizer Inc. on Friday said patients  taking its blockbuster arthritis drug Celebrex in a long-term  cancer-prevention trial had more than twice the number of fatal  or non-fatal heart attacks as those taking a placebo. 